These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19833483)

  • 1. Antipsychotic effects on auditory sensory gating in schizophrenia patients.
    Sánchez-Morla EM; Santos JL; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):905-9. PubMed ID: 19833483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P50 gating at acute and post-acute phases of first-episode schizophrenia.
    Devrim-Uçok M; Keskin-Ergen HY; Uçok A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
    Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
    Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
    Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
    Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P50 sensory gating in panic disorder.
    Ghisolfi ES; Heldt E; Zanardo AP; Strimitzer IM; Prokopiuk AS; Becker J; Cordioli AV; Manfro GG; Lara DR
    J Psychiatr Res; 2006 Sep; 40(6):535-40. PubMed ID: 16616936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.
    Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S
    Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired sensorimotor gating of the acoustic startle response in the prodrome of schizophrenia.
    Quednow BB; Frommann I; Berning J; Kühn KU; Maier W; Wagner M
    Biol Psychiatry; 2008 Nov; 64(9):766-73. PubMed ID: 18514166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers.
    Oranje B; Wienberg M; Glenthoj BY
    Psychiatry Res; 2011 Apr; 186(2-3):431-6. PubMed ID: 20971512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential.
    Patterson JV; Sandman CA; Ring A; Jin Y; Bunney WE
    Bipolar Disord; 2009 Sep; 11(6):596-609. PubMed ID: 19689502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of midlatency auditory sensory gating at short and long interstimulus intervals.
    Rentzsch J; de Castro AG; Neuhaus A; Jockers-Scherübl MC; Gallinat J
    Neuropsychobiology; 2008; 58(1):11-8. PubMed ID: 18781086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.
    Zhang J; Abdallah CG; Wang J; Wan X; Liang C; Jiang L; Liu Y; Huang H; Hong X; Huang Q; Wu R; Xu C
    Psychiatry Res; 2012 Dec; 200(2-3):126-32. PubMed ID: 22705363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients.
    Boutros NN; Brockhaus-Dumke A; Gjini K; Vedeniapin A; Elfakhani M; Burroughs S; Keshavan M
    Schizophr Res; 2009 Sep; 113(2-3):339-46. PubMed ID: 19524407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia.
    Micoulaud-Franchi JA; Aramaki M; Geoffroy PA; Richieri R; Cermolacce M; Faget C; Ystad S; Kronland-Martinet R; Lancon C; Vion-Dury J
    J Clin Psychopharmacol; 2015 Apr; 35(2):184-7. PubMed ID: 25587694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
    Light GA; Geyer MA; Clementz BA; Cadenhead KS; Braff DL
    Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
    Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
    Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P50 gating in deficit and nondeficit schizophrenia.
    Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
    Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.